AIMC Topic: Drug Discovery

Clear Filters Showing 1291 to 1300 of 1689 articles

Computational probing protein-protein interactions targeting small molecules.

Bioinformatics (Oxford, England)
MOTIVATION: With the booming of interactome studies, a lot of interactions can be measured in a high throughput way and large scale datasets are available. It is becoming apparent that many different types of interactions can be potential drug target...

Connecting proteins with drug-like compounds: Open source drug discovery workflows with BindingDB and KNIME.

Database : the journal of biological databases and curation
Today's large, public databases of protein-small molecule interaction data are creating important new opportunities for data mining and integration. At the same time, new graphical user interface-based workflow tools offer facile alternatives to cust...

Neural-Network Scoring Functions Identify Structurally Novel Estrogen-Receptor Ligands.

Journal of chemical information and modeling
The magnitude of the investment required to bring a drug to the market hinders medical progress, requiring hundreds of millions of dollars and years of research and development. Any innovation that improves the efficiency of the drug-discovery proces...

Inferring Association between Compound and Pathway with an Improved Ensemble Learning Method.

Molecular informatics
Emergence of compound molecular data coupled to pathway information offers the possibility of using machine learning methods for compound-pathway associations' inference. To provide insights into the global relationship between compounds and their af...

Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.

PLoS neglected tropical diseases
BACKGROUND: Chagas disease is a neglected tropical disease (NTD) caused by the eukaryotic parasite Trypanosoma cruzi. The current clinical and preclinical pipeline for T. cruzi is extremely sparse and lacks drug target diversity.

Comparing the Influence of Simulated Experimental Errors on 12 Machine Learning Algorithms in Bioactivity Modeling Using 12 Diverse Data Sets.

Journal of chemical information and modeling
To date, no systematic study has assessed the effect of random experimental errors on the predictive power of QSAR models. To address this shortage, we have benchmarked the noise sensitivity of 12 learning algorithms on 12 data sets (15,840 models in...

The role of machine learning in neuroimaging for drug discovery and development.

Psychopharmacology
Neuroimaging has been identified as a potentially powerful probe for the in vivo study of drug effects on the brain with utility across several phases of drug development spanning preclinical and clinical investigations. Specifically, neuroimaging ca...

Efficient heuristics for maximum common substructure search.

Journal of chemical information and modeling
Maximum common substructure search is a computationally hard optimization problem with diverse applications in the field of cheminformatics, including similarity search, lead optimization, molecule alignment, and clustering. Most of these application...

MLViS: A Web Tool for Machine Learning-Based Virtual Screening in Early-Phase of Drug Discovery and Development.

PloS one
Virtual screening is an important step in early-phase of drug discovery process. Since there are thousands of compounds, this step should be both fast and effective in order to distinguish drug-like and nondrug-like molecules. Statistical machine lea...

Machine-learning scoring functions for identifying native poses of ligands docked to known and novel proteins.

BMC bioinformatics
BACKGROUND: Molecular docking is a widely-employed method in structure-based drug design. An essential component of molecular docking programs is a scoring function (SF) that can be used to identify the most stable binding pose of a ligand, when boun...